Aijun Liu

1.5k total citations
66 papers, 956 citations indexed

About

Aijun Liu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Aijun Liu has authored 66 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Aijun Liu's work include Multiple Myeloma Research and Treatments (19 papers), Peptidase Inhibition and Analysis (17 papers) and Congenital Heart Disease Studies (7 papers). Aijun Liu is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Peptidase Inhibition and Analysis (17 papers) and Congenital Heart Disease Studies (7 papers). Aijun Liu collaborates with scholars based in China, United States and Canada. Aijun Liu's co-authors include John A. Katzenellenbogen, Michael J. Welch, Junwu Su, Aitao Guo, Martin E. Nau, Yidong Chen, Syed Shaheduzzaman, György Petrovics, Isabell A. Sesterhenn and Judd W. Moul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Aijun Liu

61 papers receiving 938 citations

Peers

Aijun Liu
Aijun Liu
Citations per year, relative to Aijun Liu Aijun Liu (= 1×) peers Jesco Pfitzenmaier

Countries citing papers authored by Aijun Liu

Since Specialization
Citations

This map shows the geographic impact of Aijun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Liu more than expected).

Fields of papers citing papers by Aijun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aijun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Liu. The network helps show where Aijun Liu may publish in the future.

Co-authorship network of co-authors of Aijun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Aijun Liu. A scholar is included among the top collaborators of Aijun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aijun Liu. Aijun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Aijun, et al.. (2025). Structural basis of CXCR4 assembly and regulation. Cell Reports. 44(2). 115255–115255. 3 indexed citations
2.
Yang, Lu, et al.. (2024). Research Progress of DNA Methylation Markers for Endometrial Carcinoma Diagnosis. Journal of Cancer. 16(3). 812–820. 2 indexed citations
3.
Liu, Aijun, Geng Chen, Fang Ye, et al.. (2024). Structure of G protein-coupled receptor GPR1 bound to full-length chemerin adipokine reveals a chemokine-like reverse binding mode. PLoS Biology. 22(10). e3002838–e3002838. 2 indexed citations
4.
Wang, Xiaoxue, Aijun Liu, Ying Zhu, et al.. (2024). Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis. Acta Pharmaceutica Sinica B. 14(8). 3493–3512. 5 indexed citations
6.
Liu, Aijun, Lihong Liu, Wei Wang, et al.. (2023). Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China. BMC Cancer. 23(1). 930–930. 1 indexed citations
9.
Song, Zaiwei, Lan Ma, Li Bao, et al.. (2022). Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship. Frontiers in Pharmacology. 13. 931495–931495. 2 indexed citations
10.
Su, Junwu, Aijun Liu, Xiangming Fan, et al.. (2019). Correction of simple congenital heart defects by right axillary thoracotomy in adults. Journal of Cardiac Surgery. 34(11). 1172–1177. 1 indexed citations
11.
Gao, Wen, Jie Li, Yuan Jian, et al.. (2018). Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation. International Journal of Hematology. 109(2). 169–174. 11 indexed citations
12.
Liu, Aijun, et al.. (2016). Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways. Experimental and Therapeutic Medicine. 11(3). 998–1004. 32 indexed citations
15.
Liu, Aijun, Xiaofeng Li, Xiangming Fan, et al.. (2014). Midterm results of diagnostic treatment and repair strategy in older patients presenting with nonrestrictive ventricular septal defect and severe pulmonary artery hypertension. Chinese Medical Journal. 127(5). 839–844. 4 indexed citations
16.
Zhu, Yaobin, Donghai Liu, Yanbo Zhang, et al.. (2013). Total liquid ventilation reduces oleic acid-induced lung injury in piglets. Chinese Medical Journal. 126(22). 4282–4288. 2 indexed citations
17.
Liu, Aijun, et al.. (2013). Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: A case report. Experimental and Therapeutic Medicine. 6(4). 883–886. 6 indexed citations
19.
Liu, Nian, Aijun Liu, Yun Leng, et al.. (2012). Retrospective analysis of 264 multiple myeloma patients. Oncology Letters. 5(2). 707–713. 9 indexed citations
20.
Li, Yali, et al.. (2011). Primary ovarian leiomyosarcoma:arebort of three cases report and review of literature. SHILAP Revista de lepidopterología. 36(1). 68–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026